ATF6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.737800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.165800E-01
Normal-vs-Stage2
7.518000E-01
Normal-vs-Stage3
1.513240E-01
Normal-vs-Stage4
2.219000E-01
Stage1-vs-Stage2
8.611400E-01
Stage1-vs-Stage3
5.354200E-02
Stage1-vs-Stage4
1.108650E-01
Stage2-vs-Stage3
9.428000E-02
Stage2-vs-Stage4
3.409800E-02
Stage3-vs-Stage4
7.695600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.555000E-01
Normal-vs-AfricanAmerican
1.681970E-01
Normal-vs-Asian
8.141400E-01
Caucasian-vs-AfricanAmerican
1.588220E-02
Caucasian-vs-Asian
8.032000E-01
AfricanAmerican-vs-Asian
1.479550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.924000E-01
Normal-vs-Female
7.562200E-01
Male-vs-Female
8.712400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.995400E-01
Normal-vs-Age(41-60Yrs)
5.612000E-01
Normal-vs-Age(61-80Yrs)
8.892800E-01
Normal-vs-Age(81-100Yrs)
9.417000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.835800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.177400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.085400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.908300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.616000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.625400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.258800E-01
Normal-vs-Daily Drinker
5.037800E-01
Normal-vs-Weekly Drinker
9.100800E-01
Normal-vs-Occasional Drinker
4.245800E-01
Normal-vs-Social Drinker
7.181200E-01
Non Drinker-vs-Daily Drinker
2.368200E-01
Non Drinker-vs-Weekly Drinker
6.845600E-01
Non Drinker-vs-Occasional Drinker
4.240000E-02
Non Drinker-vs-Social Drinker
3.483600E-01
Daily Drinker-vs-Weekly Drinker
2.077000E-01
Daily Drinker-vs-Occasional Drinker
6.202500E-03
Daily Drinker-vs-Social Drinker
6.995500E-02
Weekly Drinker-vs-Occasional Drinker
2.357000E-01
Weekly Drinker-vs-Social Drinker
7.069600E-01
Occasional Drinker-vs-Social Drinker
3.809200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.993420E-01
Normal-vs-Grade 2
6.729500E-02
Normal-vs-Grade 3
3.733500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.025600E-01
Grade 1-vs-Grade 3
1.326650E-01
Grade 1-vs-Grade 4
1.993420E-01
Grade 2-vs-Grade 3
2.767200E-01
Grade 2-vs-Grade 4
6.729500E-02
Grade 3-vs-Grade 4
3.733500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.792800E-01
Normal-vs-NonDiabetic
8.667200E-01
Diabetic-vs-NonDiabetic
5.454000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.334000E-01
Normal-vs-NoPancreatitis
8.374200E-01
Pancreatitis-vs-NoPancreatitis
3.246400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.052200E-01
Normal-vs-N1
7.896800E-01
N0-vs-N1
6.644000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.082800E-01
Normal-vs-TP53-NonMutant
5.890000E-01
TP53-Mutant-vs-TP53-NonMutant
6.626400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
